生物谷報道：蛋白質B-crystallin主要存在於眼睛的晶狀體中，它在多發性硬化中所發生的炎症和損傷的發展過程中可能是關鍵的.“引爆點”。過去，人們知道它是多發性硬化患者體內1個主要免疫目標。現在，用小鼠所做的研究工作表明，該蛋白在1個多發性硬化模型中還扮演1個保護角色。當將其注射進實驗鼠體內時，它起1種消炎和神經保護因子的作用，並且還能使癱瘓發生逆轉。
原始出處:
Nature 448, 474-479 (26 July 2007) | doi:10.1038/nature05935; Received 6 March 2007; Accepted 17 May 2007; Published online 13 June 2007
Protective and therapeutic role for B-crystallin in autoimmune demyelination
Shalina S. Ousman1, Beren H. Tomooka2,3, Johannes M. van Noort4, Eric F. Wawrousek5, Kevin O'Conner6, David A. Hafler6, Raymond A. Sobel7, William H. Robinson2,3 & Lawrence Steinman1
- Department of Neurology and Neurological Sciences, Stanford UniversityDivision of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California 94305, USAGRECC and,Laboratory Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304, USADepartment of Biosciences, TNO Quality of Life, 2301 CE Leiden, The NetherlandsNational Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USACenter for Neurologic Disease, Harvard Medical School, Brigham and Women's Hospital, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA
Correspondence to: Lawrence Steinman1 Correspondence and requests for materials should be addressed to L.S. ).
B-crystallin (CRYAB) is the most abundant gene transcript present in early active multiple sclerosis lesions, whereas such transcripts are absent in normal brain tissue1. This crystallin has anti-apoptotic2, 3, 4, 5, 6, 7 and neuroprotective8 functions. CRYAB is the major target of CD4+ T-cell immunity to the myelin sheath from multiple sclerosis brain9, 10. The pathophysiological implications of this immune response were investigated here. We demonstrate that CRYAB is a potent negative regulator acting as a brake on several inflammatory pathways in both the immune system and central nervous system (CNS). Cryab-/- mice showed worse experimental autoimmune encephalomyelitis (EAE) at the acute and progressive phases, with higher Th1 and Th17 cytokine secretion from T cells and macrophages, and more intense CNS inflammation, compared with their wild-type counterparts. Furthermore, Cryab-/- astrocytes showed more cleaved caspase-3 and more TUNEL staining, indicating an anti-apoptotic function of Cryab. Antibody to CRYAB was detected in cerebrospinal fluid from multiple sclerosis patients and in sera from mice with EAE. Administration of recombinant CRYAB ameliorated EAE. Thus, the immune response against a negative regulator of inflammation, CRYAB, in multiple sclerosis, would exacerbate inflammation and demyelination. This can be countered by giving CRYAB itself for therapy of ongoing disease.
圖：Myelin antigen array analysis demonstrates antibody targeting of CRYAB in RRMS patients.
相關報道:
PNAS：中國多發性硬化免疫病理機制研究取得新突破
多發性硬化病人標準護理計劃
辛伐他汀可治多發性硬化症對腦部損傷
研究證實維生素D有預防多發性硬化的作用
德科學家發現與多發性硬化症有關的物質
口服避孕藥有助預防多發性硬化症
柳葉刀：β-干擾素可減緩多發性硬化症
多發性硬化等自身免疫性疾病治療新探索
研究發現1種多發性硬化症藥物有助降低毒癮
多發性硬化研究進展(述評)